Author

Bo Shao

Institutions: Guizhou University, Liaoning Cancer Hospital & Institute

Observed institutions: Guizhou University, Liaoning Cancer Hospital & Institute

OpenAlex ID: A5153589360

Efficacy and safety of first- versus second-generation fibroblast growth factor receptor (FGFR) inhibitors in advanced or metastatic urothelial carcinoma with FGFR alterations: a systematic review and meta-analysis

2026 · Zhe Wang, Bo Shao, et al. · Frontiers in Pharmacology

Decoding the temporal dimension of innate immunity in intravesical BCG therapy

2026 · Xuewen Diao, Bangwei Che, et al. · Frontiers in Immunology

Works count: 2

Citation count:

H-index:

I10-index: